To determine the role of LAT2-mediated amino acid uptake in doxorubicin-induced osteosarcoma immune evasion, we subcutaneously injected LAT2-depleted HOS cells into nude mice and treated the tumor-bearing mice with doxorubicin. Here, LAT2 is linked to neoplasm.